Developing research impact: influencing public policy
Working with policy-makers is a really useful way of getting research recognised and used by professionals in the relevant field, resulting in an impact on society.
Not only can attempting to influence policy raise the profile of the research and have profound implications for society, it can also considerably raise the profile of the academic behind the research, creating room for possible new partnerships and future collaboration.
What is policy-influencing?
Policy-makers bring together evidence and politics to come up with policies and solutions for issues that affect everyone on a daily basis. They can incorporate a range of individuals; including those who are elected into political positions and civil servants who work in government departments, meaning there are a variety of ways in which research can lead to influencing policy.
Research can be particularly influential in policy influencing as it could provide the basis for an evidence-based change or amendment to legislation. This can be a very powerful way of developing research impact, but it can also be a very complex process.
How can you find out more?
For more information, contact BU’s Policy team: Jane Forster and Sarah Carter or see BU’s staff intranet.











Psychology, Psychiatry and Neuroscience academics – would you like to get more involved in preparing our next REF submission?
Three Minute Thesis (3MT®) 2026: Register to Support our PGRs
Expressions of Interest invited for Research Ethics Roles starting in 2026/27
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease